Single Source Competition for Biostatistical and Coordinating Center Renewal of the NIDDK CLEAR Study Consortium (Closed-Loop and Education for Hypoglycemia Awareness Restoration) (U24- Resource-Related Research Project, Cooperative Agreements)
Agency: National Institutes of Health
- 93.KT1 -- Diabetes, Digestive, Kidney Extramural Research - Special Diabetes Program
- 93.KRC -- Diabetes, Digestive, Kidney Extramural Research - Research Centers
Forecasted opportunityLast Updated: Nov 18, 2026
Important dates
- Forecasted post date: May 10, 2027
- Forecasted application due date: June 10, 2027
- Forecasted award date: March 1, 2028
- Forecasted project start date: March 10, 2028
- Fiscal Year: 2028
Award details
- Expected project funding: $4,700,000
- Expected awards: 1
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:RFA-DK-28-117
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: November 18, 2026
- Archive date: Not specified
- Version: 1
Summary
This NOFO invites a single source application for the continuation of the Biostatistics and Coordinating Center (BCC) at Pennsylvania State University-Hershey Medical Center during a 3-year continuation of the CLEAR (Closed Loop and Education for Hypglycemia Awareness Restoration) Study Consortium. This BCC team has provided extensive logistical and statistical support for the CLEAR-Study Consortium since its inception in FY2022. The continuation/ renewal of the CLEAR Study Consortium is for the period of January 2028-December 2030. The BCC at Pennsylvania State University-Hershey Medical Center will continue to include a domestic sub-award to the JAEB Center for Health Research for digital device management. A separate NOFO (RFA-DK28-118) will be utilized to invite 8 currently active clinical centers (CCs) to apply for a 3-year continuation.
The goal of the CLEAR Study Consortium remains to examine the ability of current technology, including continuous glucose monitoring coupled with automated insulin delivery (referred to as hybrid closed loop (HCL) systems), and advanced education on hypoglycemia avoidance to prevent recurrent hypoglycemia and, through that mechanism, restore awareness of hypoglycemia in patients with type 1 diabetes (T1D) with impaired awareness of hypoglycemia (IAH).
The consortium is utilizing state of the art metabolic assessments such as hypoglycemic, hyperinsulinemic clamps for the measurement of CRRs in epinephrine and hypoglycemia symptom scores to identify restoration of awareness, examine heterogeneity in the ability to restore awareness of hypoglycemia, validate self-report assessments that are currently used to identify patients with IAH.
Eligibility
Education
- Public and state institutions of higher education
Miscellaneous
- Other
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: NIDDK_DEM@nih.gov
NIDDK_DEM@nih.gov
Link to additional information
No additional information is available
